CORC  > 湖南大学
Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma
Chao Wang; Yan Li; Chuan-min Chu; Xiang-min Zhang; Jie Ma; Hai Huang; Yu-ning Wang; Tian-yu Hong; Jing Zhang; Xiu-wu Pan
刊名EBioMedicine
2019
卷号Vol.39页码:255-264
关键词Renal cell carcinoma Gankyrin Prognosis Disease progression
ISSN号2352-3964
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4737378
专题湖南大学
作者单位1.e Department of Urinary Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin Road No. 2, Shanghai 200025, China f Department of Microbiology and Immunology, Weill Medical College of Cornell University, 1300 York Avenue, New York 10065-4805, NY, United States.
2.Ningxia Medical University, Yinchuan, Ningxia 750004, China a Department of Urinary Surgery, Gongli Hospital, Second Military Medical University , 219 Miaopu Road, Shanghai 200135, China
3.Department of Urinary Surgery, The Third Affiliated Hospital of Second Military Medical University , 700 North Moyu Road, Shanghai 201805, China
4.Department of Urology, Changhai Hospital, Second Military Medical University , 168 Changhai Road, Shanghai 200438, China
推荐引用方式
GB/T 7714
Chao Wang,Yan Li,Chuan-min Chu,et al. Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma[J]. EBioMedicine,2019,Vol.39:255-264.
APA Chao Wang.,Yan Li.,Chuan-min Chu.,Xiang-min Zhang.,Jie Ma.,...&Xin-gang Cui.(2019).Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.EBioMedicine,Vol.39,255-264.
MLA Chao Wang,et al."Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma".EBioMedicine Vol.39(2019):255-264.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace